Metabolic Imaging in B-Cell Lymphomas during CAR-T Cell Therapy

SIMPLE SUMMARY: Chimeric antigen receptor–engineered T cells are an innovative therapy in hematologic malignancies, especially in patients with refractory/relapsed B-cell lymphomas. Few studies have analyzed the role of [(18)F]FDG PET/CT in this field; this review aims to illustrate the literature d...

Descripción completa

Detalles Bibliográficos
Autores principales: Linguanti, Flavia, Abenavoli, Elisabetta Maria, Berti, Valentina, Lopci, Egesta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9562671/
https://www.ncbi.nlm.nih.gov/pubmed/36230629
http://dx.doi.org/10.3390/cancers14194700

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9562671/
https://www.ncbi.nlm.nih.gov/pubmed/36230629
http://dx.doi.org/10.3390/cancers14194700

Ejemplares similares